Interleukin-1 and Neurodegenerative Diseases
Author Information
Author(s): Griffin W Sue T, Liu Ling, Li Yuekui, Mrak Robert E, Barger Steven W
Primary Institution: University of Arkansas for Medical Sciences
Hypothesis
Does interleukin-1 mediate the pathologies associated with Alzheimer's and Lewy body diseases?
Conclusion
IL-1 drives the production of substrates necessary for the formation of major neuropathological changes characteristic of Alzheimer's and Lewy body diseases.
Supporting Evidence
- IL-1β treatment of neurons increased sAPP release in a dose-dependent manner.
- Microglial activation with sAPPα led to increased IL-1β secretion.
- In vivo studies showed that IL-1β elevated α-synuclein mRNA levels in rat brains.
Takeaway
This study shows that a protein called IL-1 can make brain cells produce more harmful substances that are linked to diseases like Alzheimer's and Parkinson's.
Methodology
The study used rat primary cultures of microglia and cortical neurons, treated them with IL-1β, and analyzed mRNA for various neuropathological markers.
Participant Demographics
5 patients with combined AD/LBD, 2 males and 3 females, aged 68–85.
Statistical Information
P-Value
p<0.02
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website